
Simcere Pharmaceutical Group Ltd
HKEX:2096

Intrinsic Value
The intrinsic value of one
Simcere Pharmaceutical Group Ltd
stock under the Base Case scenario is
11.91
HKD.
Compared to the current market price of 11.02 HKD,
Simcere Pharmaceutical Group Ltd
is
Undervalued by 7%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Simcere Pharmaceutical Group Ltd
Loading...
Fundamental Analysis


Revenue & Expenses Breakdown
Simcere Pharmaceutical Group Ltd
Balance Sheet Decomposition
Simcere Pharmaceutical Group Ltd
Current Assets | 5.5B |
Cash & Short-Term Investments | 1.9B |
Receivables | 2.8B |
Other Current Assets | 758.2m |
Non-Current Assets | 6B |
Long-Term Investments | 1.9B |
PP&E | 2.3B |
Intangibles | 1.2B |
Other Non-Current Assets | 713.9m |
Free Cash Flow Analysis
Simcere Pharmaceutical Group Ltd
CNY | |
Free Cash Flow | CNY |
Earnings Waterfall
Simcere Pharmaceutical Group Ltd
Revenue
|
6.6B
CNY
|
Cost of Revenue
|
-1.3B
CNY
|
Gross Profit
|
5.3B
CNY
|
Operating Expenses
|
-4.2B
CNY
|
Operating Income
|
1.1B
CNY
|
Other Expenses
|
-402.6m
CNY
|
Net Income
|
733.2m
CNY
|
Profitability Score
Profitability Due Diligence
Simcere Pharmaceutical Group Ltd's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

Score
Simcere Pharmaceutical Group Ltd's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Simcere Pharmaceutical Group Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Score
Simcere Pharmaceutical Group Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Simcere Pharmaceutical Group Ltd
According to Wall Street analysts, the average 1-year price target for
Simcere Pharmaceutical Group Ltd
is 10.24 HKD
with a low forecast of 7.68 HKD and a high forecast of 15.02 HKD.
Dividends
Current shareholder yield for Simcere Pharmaceutical Group Ltd is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
Simcere Pharmaceutical Group Ltd
stock under the Base Case scenario is
11.91
HKD.
Compared to the current market price of 11.02 HKD,
Simcere Pharmaceutical Group Ltd
is
Undervalued by 7%.